Antimalarial drug discovery: screening of Brazilian medicinal plants and purified compounds
- 2 February 2009
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 4 (2) , 95-108
Abstract
Background: Malaria is the most important parasitic disease and its control depends on specific chemotherapy, now complicated by Plasmodium falciparum that has become resistant to most commonly available antimalarials. Treatment of the disease requires quinine or drug combinations of artemisinin derivatives and other antimalarials. Further drug resistance is expected. New active compounds need to be discovered. Objective/method: To find new antimalarials from medicinal and randomly collected plants, crude extracts are screened against P. falciparum in cultures and in malaria animal models, following bioassays of purified fractions, and cytotoxicity tests. Conclusion: For antimalarial research, screening medicinal plants is more efficient than screening randomly chosen plants. Biomonitored fractionation allows selection of new active molecules identified as potential antimalarials in multidisciplinary projects in Brazil; no new molecule is available for human testing. The advantages of projects based on et...Keywords
This publication has 50 references indexed in Scilit:
- Ampelozyziphus amazonicus Ducke (Rhamnaceae), a medicinal plant used to prevent malaria in the Amazon Region, hampers the development of Plasmodium berghei sporozoitesInternational Journal for Parasitology, 2008
- Malaria Diagnosis and Hospitalization Trends, BrazilEmerging Infectious Diseases, 2007
- Ethnopharmacology and malaria: New hypothetical leads or old efficient antimalarials?International Journal for Parasitology, 2007
- Antiplasmodial Activity of Aryltetralone Lignans from Holostylis reniformisAntimicrobial Agents and Chemotherapy, 2007
- Validation of a Plasmodium falciparum parasite transformed with green fluorescent protein for antimalarial drug screeningJournal of Microbiological Methods, 2007
- A Plant-Derived Morphinan as a Novel Lead Compound Active against Malaria Liver StagesPLOS Medicine, 2006
- Cost-Effectiveness Study of Three Antimalarial Drug Combinations in TanzaniaPLOS Medicine, 2006
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malariaParasitology Today, 1996
- Human Malaria Parasites in Continuous CultureScience, 1976